Traws Pharma preps revised toxicology data for MHRA resubmission by Q3 2026Aug 14Regulatory decisionTraws Pharma, Inc.
Traws Pharma files prospectus supplement for up to $5.58 million at-the-market stock saleJul 10FinancingTraws Pharma, Inc.
Traws Pharma stockholders approve share increase, elect directors at annual meetingJul 9PeopleTraws Pharma, Inc.
Sign in